ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,679Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 256

$1.97M Total Retail Price of All Prescriptions

Rank: 1 out of 256

562 Patients Receiving at Least One Drug in Part D
17% Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Minnesota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

13% of this provider’s 562 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs*

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$111 was the average price of a prescription from this provider, compared to $122 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
CLONAZEPAM 903 71 117 B 1 2
ZOLPIDEM TARTRATE 679 58 110 2 18
BUPROPION XL 678 87 90 3 13
TRAZODONE HCL 659 141 122 4 3
RISPERIDONE 654 100 106 A 5 4
CLOZAPINE 640 16 36 A 6 5
OLANZAPINE 626 95 81 A 7 7
LORAZEPAM 608 77 103 B 8 9
SERTRALINE HCL 553 83 81 9 8
QUETIAPINE FUMARATE 533 49 67 A 10 1
VENLAFAXINE HCL ER 531 40 71 11 10
DIAZEPAM 437 27 59 B 12 33
ALPRAZOLAM 422 79 74 B 13 23
PAROXETINE HCL 419 70 58 14 26
ABILIFY 412 103 61 A 15 6
CITALOPRAM HBR 392 67 61 16 11
MIRTAZAPINE 381 66 56 17 16
BUSPIRONE HCL 375 39 56 18 21
TEMAZEPAM 372 47 53 B 19 37
FLUOXETINE HCL 355 43 48 20 15
ESCITALOPRAM OXALATE 342 31 59 21 17
LITHIUM CARBONATE 340 21 46 22 24
LAMOTRIGINE 331 <11 48 23 14
DIVALPROEX SODIUM ER 329 <11 46 24 20
CYMBALTA 323 41 42 25 12
BENZTROPINE MESYLATE 311 <11 40 R 26 19
ZIPRASIDONE HCL 265 <11 37 A 27 25
DIVALPROEX SODIUM 263 25 40 28 28
GABAPENTIN 252 28 36 29 22
TOPIRAMATE 215 <11 33 30 29
AMPHETAMINE SALT COMBO 196 50 24 S2 31 30
DEXTROAMPHETAMINE-AMPHETAMINE 170 <11 23 S2 32 42
LATUDA 148 0 22 A 33 43
DOXEPIN HCL 133 0 20 34 54
METHYLPHENIDATE HCL 121 <11 18 S2 35 41
PROPRANOLOL HCL 106 <11 17 36 39
ZOLPIDEM TARTRATE ER 105 <11 16 37 61
LUNESTA 103 21 27 38 45
PRAZOSIN HCL 98 0 15 39 44
HYDROXYZINE PAMOATE 96 0 21 R 40 34
VIIBRYD 86 <11 12 41 53
HALOPERIDOL 84 0 13 A 42 31
FLUVOXAMINE MALEATE 81 18 13 43 49
NORTRIPTYLINE HCL 80 0 15 44 55
CLOZAPINE ODT 74 <11 <11 A 45 67
BUPROPION HCL SR 72 29 11 46 27
OXCARBAZEPINE 72 <11 <11 46 36
CHLORPROMAZINE HCL 67 <11 <11 A 48 73
METHYLPHENIDATE ER 66 <11 <11 S2 49 87
NALTREXONE HCL 66 0 13 49 88
METFORMIN HCL 59 0 12 51 108
DESMOPRESSIN ACETATE 57 <11 <11 52 86
CLONIDINE HCL 56 <11 <11 53 58
LOXAPINE 56 <11 <11 A 53 72
ROPINIROLE HCL 54 <11 <11 55 82
AMITRIPTYLINE HCL 54 <11 <11 R 55 56
CLOMIPRAMINE HCL 54 <11 <11 R 55 92
ZALEPLON 52 <11 13 58 69
FANAPT 52 <11 <11 A 58 60
SAPHRIS 52 0 11 A 58 59
INVEGA 52 0 12 A 58 50
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.